ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Ophthalmology

Top Ophthalmology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LEO WANG MD

Ophthalmology

7,722

$505K

1034
968 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 60%

$65
Average prescription price

Avg: $65

JOHN GEANON MD

Ophthalmology

5,698

$549K

708
662 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 60%

$96
Average prescription price

Avg: $65

RICHARD PATCHETT MD

Ophthalmology

4,913

$275K

571
525 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 60%

$56
Average prescription price

Avg: $65

JOSEPH BERGMANN M.D.

Ophthalmology

4,515

$313K

630
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

67%
prescriptions for brand name drugs

Avg: 60%

$69
Average prescription price

Avg: $65

JAMES ROBINSON MD

Ophthalmology

4,257

$303K

512
424 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 60%

$71
Average prescription price

Avg: $65

KEVIN WIENKERS MD

Ophthalmology

3,892

$179K

860
803 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 60%

$46
Average prescription price

Avg: $65

GLENN GRAVES M.D.

Ophthalmology

3,621

$294K

625
591 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 60%

$81
Average prescription price

Avg: $65

KURT SCHWIESOW MD

Ophthalmology

3,532

$194K

664
611 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 60%

$55
Average prescription price

Avg: $65

KAMAL NASSIF M.D.

Ophthalmology

3,493

$305K

566
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 60%

$87
Average prescription price

Avg: $65

JOHN YOON MD

Ophthalmology

3,423

$225K

642
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 60%

$66
Average prescription price

Avg: $65

WILLIAM VERRE M.D.

Ophthalmology

3,397

$350K

721
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 60%

$103
Average prescription price

Avg: $65

NORMAN COHEN M.D.

Ophthalmology

3,339

$232K

660
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $65

MICHEAL VRABEC M.D.

Ophthalmology

3,200

$259K

956
886 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 60%

$81
Average prescription price

Avg: $65

MATTHEW HATTENHAUER M.D.

Ophthalmology

3,180

$185K

545
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 60%

$58
Average prescription price

Avg: $65

DANIEL FERGUSON M.D.

Ophthalmology

3,172

$198K

660
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 60%

$62
Average prescription price

Avg: $65

CHARLES YANG MD

Ophthalmology

3,073

$228K

501
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 60%

$74
Average prescription price

Avg: $65

JUDITH FITZGERALD MD

Ophthalmology

2,895

$244K

434
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 60%

$84
Average prescription price

Avg: $65

SARWAT SALIM MD

Ophthalmology

2,836

$220K

350
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $65

KARA HARBICK MD

Ophthalmology

2,823

$197K

398
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $65

TYSON SCHWIESOW MD

Ophthalmology

2,804

$140K

590
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 60%

$50
Average prescription price

Avg: $65

BRETT RHODE M.D.

Ophthalmology

2,762

$146K

651
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

76%
prescriptions for brand name drugs

Avg: 60%

$53
Average prescription price

Avg: $65

CHAD HOITINK

Ophthalmology

2,671

$242K

434
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

82%
prescriptions for brand name drugs

Avg: 60%

$90
Average prescription price

Avg: $65

DAVID LUELLWITZ D.O.

Ophthalmology

2,626

$227K

395
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 60%

$86
Average prescription price

Avg: $65

LORNE SCHLECHT MD

Ophthalmology

2,614

$162K

610
566 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 60%

$62
Average prescription price

Avg: $65

ADA HALL MD

Ophthalmology

2,589

$113K

474
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 60%

$44
Average prescription price

Avg: $65

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank